Work

340P Rezvilutamide plus androgen deprivation therapy in patients with low-volume, metastatic hormone-sensitive prostate cancer: A national, real-world cohort study

Year: 2024

Type: article

Study design: Observational Study

Source: Annals of Oncology

DOI: 10.1016/j.annonc.2024.10.359

Authors: B. Wang, S. Niu, D. Xia, Q. Zhang, J. Yu, Y. Qi, Q. Chen, L. Mao, H. Liu, Y. Liu, R. Sun, Y. Song, W. Zhang, T. Ruan, S. Zhong, X. Duan, H. Liu, X. Wang, H. Zhang, X. Zhang

Institutions: Chinese PLA General Hospital, First Affiliated Hospital Zhejiang University, Zhejiang University, Jilin Province Tumor Hospital, Liuzhou General Hospital, Foshan Second People's Hospital, Affiliated Hospital of Xuzhou Medical College, Yili Friendship Hospital, Second Affiliated Hospital of Zhejiang University, Liaocheng People's Hospital, Zaozhuang Municipal Hospital, Chenzhou First People's Hospital, Yue Bei People's Hospital, Sheng Jing Hospital, China Medical University, Taian City Central Hospital

Language: English

Topic: Prostate Cancer Treatment and Research

Subfield: Pulmonary and Respiratory Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: bronze

OpenAlex ID: W4405134961

FWCI:

Cites:

Cited by:

Related to: 10